Chikindas M L, Novák J, Driessen A J, Konings W N, Schilling K M, Caufield P W
Unilever Dental Research, United Kingdom.
Antimicrob Agents Chemother. 1995 Dec;39(12):2656-60. doi: 10.1128/AAC.39.12.2656.
Mutacin II is an antibiotic that is produced by group II Streptococcus mutans. It inhibits the growth of other streptococci as well as many other gram-positive microorganisms by a hitherto unknown mechanism. Mutacin II possess bactericidal activity against susceptible cells. It transiently depolarizes the transmembrane electrical potential (delta psi) and the transmembrane pH gradient (delta pH) and partially inhibits amino acid transport. However, it rapidly depletes the intracellular ATP pool in glucose-energized cells and prevents the generation of ATP. It is concluded that mutacin II does not belong to the group of pore-forming antibiotics (type A) or to the type B antibiotics, which inhibit phospholipases or interfere with peptidoglycan biosynthesis. Mutacin II acts by inhibiting essential enzyme functions at the level of metabolic energy generation, an activity that has not yet been classified for antibiotics.
变链菌素II是一种由II组变形链球菌产生的抗生素。它通过一种迄今未知的机制抑制其他链球菌以及许多其他革兰氏阳性微生物的生长。变链菌素II对敏感细胞具有杀菌活性。它能使跨膜电势(Δψ)和跨膜pH梯度(ΔpH)瞬间去极化,并部分抑制氨基酸转运。然而,它能迅速耗尽葡萄糖供能细胞中的细胞内ATP池,并阻止ATP的产生。得出的结论是,变链菌素II不属于形成孔道的抗生素(A型)或B型抗生素,B型抗生素抑制磷脂酶或干扰肽聚糖生物合成。变链菌素II通过在代谢能量产生水平抑制必需酶的功能来发挥作用,这种活性尚未被归类为抗生素的活性。